>ObjectivesNew antidiabetic medications such as insulin analogues and thiazolidinediones have been introduced over the last decade. This study compares the upta'/> Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand
首页> 外文期刊>Southern Med Review >Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand
【24h】

Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand

机译:在三个新兴市场吸收新的抗糖尿病药物:巴西,中国和泰国之间的比较

获取原文
           

摘要

id="__sec1" class="sec sec-first">>ObjectivesNew antidiabetic medications such as insulin analogues and thiazolidinediones have been introduced over the last decade. This study compares the uptake of new agents in three emerging pharmaceutical markets: Brazil, China, and Thailand.
机译:id =“ __ sec1” class =“ sec sec-first”> >目标在过去的十年中,人们引入了新的抗糖尿病药物,例如胰岛素类似物和噻唑烷二酮。这项研究比较了巴西,中国和泰国这三个新兴医药市场对新药的吸收。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号